Optimization of Treatment Tactics for Acute Viral Gastroenteritis in in-Patient Children

Abstract

Acute intestinal infections (ACI) being a common form of pathology in children, 50-80% of cases are due to viral agents with a predominance of rotavirus. Patients Over a two-year period, 2556 children aged from 3 months and up to 18 years old were treated in the Department of acute intestinal infections. Two groups of children with viral intestinal infections without extraintestinal bacterial foci were selected. The main group consisted of 259 children who received diet therapy, oral rehydration (ORR) and, according to indications, infusion therapy (IT). 248 children included in the comparison group (CG) received ORP, nitrofurans, antibacterial drugs, enterosorbents, enzymes, probiotics, and, according to indications, IT. Results. In no case did the children of OG receive antibacterial drugs; Compliance with parents allowed IT to be minimized to 17.4% of cases (45 children). In CG, in 74.2% of cases (184 children), patients, in addition to nitrofurans, received III generation cephalosporins, in 81.9% of cases - IT, all children received probiotics, enzymes as symptomatic therapy. Following the recommendations of WHO and ESPGHAN allows avoiding polypharmacy and reduce the economic costs of treating in-patient children with viral gastroenteritis by 3.3 times.